A Nomogram Based on Circulating CD4⁺ T Lymphocytes and Lactate Dehydrogenase to Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma

References

• Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. doi:10.1016/S0140-6736(19)30956-0
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Fu ZT, Guo XL, Zhang SW, et al. [Incidence and mortality of nasopharyngeal carcinoma in China, 2014]. Zhonghua Zhong Liu Za Zhi. 2018;40(8):566–571. Chinese. doi:10.3760/cma.j.issn.0253-3766.2018.08.002
   PubMedGoogle Scholar
• Mao YP, Tang LL, Chen L, et al. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy. Chin J Cancer. 2016;35(1):103. doi:10.1186/s40880-016-0167-2
   PubMedGoogle Scholar
• Tian YM, Liu MZ, Zeng L, et al. Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Head Neck. 2019;41(5):1246–1252. doi:10.1002/hed.25545
   PubMed Web of Science ®Google Scholar
• Huang CL, Guo R, Li JY, et al. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa. Eur Radiol. 2020;30:816–822. doi:10.1007/s00330-019-06500-5
   PubMed Web of Science ®Google Scholar
• Wu LR, Zhang XM, Xie XD, Lu Y, Wu JF, He X. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: results from a non-endemic cohort with 10-year follow-up. Oral Oncol. 2019;98:141–146. doi:10.1016/j.oraloncology.2019.09.029
   PubMed Web of Science ®Google Scholar
• Tang LL, Chen YP, Mao YP, et al. Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma from endemic areas in the intensity-modulated radiotherapy era. J Natl Compr Canc Netw. 2017;15(7):913–919. doi:10.6004/jnccn.2017.0121
   PubMed Web of Science ®Google Scholar
• Strausberg RL. Tumor microenvironments, the immune system and cancer survival. Genome Biol. 2005;6(3):211. doi:10.1186/gb-2005-6-3-211
   PubMed Web of Science ®Google Scholar
• Biswas SK. Metabolic reprogramming of immune cells in cancer progression. Immunity. 2015;43(3):435–449. doi:10.1016/j.immuni.2015.09.001
   PubMed Web of Science ®Google Scholar
• Clancy T, Pedicini M, Castiglione F, et al. Immunological network signatures of cancer progression and survival. BMC Med Genomics. 2011;4:28. doi:10.1186/1755-8794-4-28
   PubMed Web of Science ®Google Scholar
• Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol. 2013;33(Suppl 1):S79–84. doi:10.1007/s10875-012-9847-0
   PubMed Web of Science ®Google Scholar
• Gerloni M, Zanetti M. CD4 T cells in tumor immunity. Springer Semin Immunopathol. 2005;27(1):37–48. doi:10.1007/s00281-004-0193-z
   PubMed Web of Science ®Google Scholar
• Tao CJ, Chen YY, Jiang F, et al. A prognostic model combining CD4/CD8 ratio and N stage predicts the risk of distant metastasis for patients with nasopharyngeal carcinoma treated by intensity modulated radiotherapy. Oncotarget. 2016;7(29):46653–46661. doi:10.18632/oncotarget.9695
   PubMedGoogle Scholar
• Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J. 1996;9(8):1736–1742. doi:10.1183/09031936.96.09081736
   PubMed Web of Science ®Google Scholar
• Certo M, Tsai CH, Pucino V, Ho PC, Mauro C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 2021;21(3):151–161. doi:10.1038/s41577-020-0406-2
   PubMed Web of Science ®Google Scholar
• Biswas S, Lunec J, Bartlett K. Non-glucose metabolism in cancer cells–is it all in the fat? Cancer Metastasis Rev. 2012;31(3–4):689–698. doi:10.1007/s10555-012-9384-6
   PubMed Web of Science ®Google Scholar
• Long G, Tang W, Fu X, et al. Pre-treatment serum lactate dehydrogenase predicts distant metastasis and poor survival in nasopharyngeal carcinoma. J Cancer. 2019;10(16):3657–3664. doi:10.7150/jca.32716
   PubMed Web of Science ®Google Scholar
• Zhang M, Wei S, Su L, Lv W, Hong J. Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: a meta-analysis. Medicine. 2016;95(35):e4494. doi:10.1097/MD.0000000000004494
   PubMed Web of Science ®Google Scholar
• Chen X, Long X, Liang Z, et al. Higher N stage and serum ferritin, but lower serum albumin levels are associated with distant metastasis and poor survival in patients with nasopharyngeal carcinoma following intensity-modulated radiotherapy. Oncotarget. 2017;8(42):73177–73186. doi:10.18632/oncotarget.17418
   PubMedGoogle Scholar
• Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–180. doi:10.1016/S1470-2045(14)71116-7
   PubMed Web of Science ®Google Scholar
• Leung TW, Tung SY, Sze WK, et al. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck. 2005;27(7):555–565. doi:10.1002/hed.20189
   PubMed Web of Science ®Google Scholar
• Sun X, Su S, Chen C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110(3):398–403. doi:10.1016/j.radonc.2013.10.020
   PubMed Web of Science ®Google Scholar
• Xie C, Li H, Yan Y, et al. A nomogram for predicting distant metastasis using nodal-related features among patients with nasopharyngeal carcinoma. Front Oncol. 2020;10:616. doi:10.3389/fonc.2020.00616
   PubMedGoogle Scholar
• Tang XR, Li YQ, Liang SB, et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol. 2018;19(3):382–393. doi:10.1016/S1470-2045(18)30080-9
   PubMed Web of Science ®Google Scholar
• Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662–680. doi:10.1038/s41568-020-0285-7
   PubMed Web of Science ®Google Scholar
• Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306. doi:10.1038/nrc3245
   PubMed Web of Science ®Google Scholar
• Fridman WH, Zitvogel L, Sautès-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14(12):717–734. doi:10.1038/nrclinonc.2017.101
   PubMed Web of Science ®Google Scholar
• Trédan O, Manuel M, Clapisson G, et al. Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome. Eur J Cancer. 2013;49(7):1673–1682. doi:10.1016/j.ejca.2012.11.028
   PubMed Web of Science ®Google Scholar
• Péron J, Cropet C, Tredan O, et al. CD4 lymphopenia to identify end-of-life metastatic cancer patients. Eur J Cancer. 2013;49(5):1080–1089. doi:10.1016/j.ejca.2012.11.003
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu Y, Wang J, et al. A comprehensive model based on temporal dynamics of peripheral T cell repertoire for predicting post-treatment distant metastasis of nasopharyngeal carcinoma. Cancer Immunol Immunother. 2021:1–14. doi:10.1007/s00262-021-03016-0
   PubMed Web of Science ®Google Scholar
• Fu Y, Lan T, Cai H, Lu A, Yu W. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma. Medicine. 2018;97(19):e0741. doi:10.1097/MD.0000000000010741
   PubMed Web of Science ®Google Scholar
• Shen J, Chen Z, Zhuang Q, et al. Prognostic value of serum lactate dehydrogenase in renal cell carcinoma: a systematic review and meta-analysis. PLoS One. 2016;11(11):e0166482. doi:10.1371/journal.pone.0166482
   PubMed Web of Science ®Google Scholar
• Deng T, Zhang J, Meng Y, Zhou Y, Li W. Higher pretreatment lactate dehydrogenase concentration predicts worse overall survival in patients with lung cancer. Medicine. 2018;97(38):e12524. doi:10.1097/MD.0000000000012524
   PubMed Web of Science ®Google Scholar
• Chen Z, Guo Q, Lu T, et al. Pretreatment serum lactate dehydrogenase level as an independent prognostic factor of nasopharyngeal carcinoma in the intensity-modulated radiation therapy era. Med Sci Monit. 2017;23:437–445. doi:10.12659/MSM.899531
   PubMed Web of Science ®Google Scholar
• Zhou GQ, Ren XY, Mao YP, et al. Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Sci Rep. 2016;6:22326. doi:10.1038/srep22326
   PubMed Web of Science ®Google Scholar
• Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211–218. doi:10.1016/j.tibs.2015.12.001
   PubMed Web of Science ®Google Scholar
• Siska PJ, Singer K, Evert K, Renner K, Kreutz M. The immunological Warburg effect: can a metabolic-tumor-stroma score (MeTS) guide cancer immunotherapy? Immunol Rev. 2020;295(1):187–202. doi:10.1111/imr.12846
   PubMed Web of Science ®Google Scholar
• Shen L, Zhou Y, He H, et al. Crosstalk between macrophages, T cells, and iron metabolism in tumor microenvironment. Oxid Med Cell Longev. 2021;2021:8865791. doi:10.1155/2021/8865791
   PubMed Web of Science ®Google Scholar
• Wang SL, Cao S, Wu R, et al. Serum ferritin predicted prognosis in patients with locally advanced pancreatic cancer. Future Oncol. 2015;11(21):2905–2910. doi:10.2217/fon.15.186
   PubMed Web of Science ®Google Scholar
• Song A, Eo W, Kim S, Shim B, Lee S. Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study. BMC Complement Altern Med. 2018;18(1):176. doi:10.1186/s12906-018-2240-7
   PubMedGoogle Scholar
• Lee S, Song A, Eo W. Serum ferritin as a prognostic biomarker for survival in relapsed or refractory metastatic colorectal cancer. J Cancer. 2016;7(8):957–964. doi:10.7150/jca.14797
   PubMed Web of Science ®Google Scholar
• Hsu MY, Mina E, Roetto A, Porporato PE. Iron: an essential element of cancer metabolism. Cells. 2020;9:12. doi:10.3390/cells9122591
   Web of Science ®Google Scholar
• Pfeifhofer-Obermair C, Tymoszuk P, Petzer V, Weiss G, Nairz M. Iron in the tumor microenvironment-connecting the dots. Front Oncol. 2018;8:549. doi:10.3389/fonc.2018.00549
   PubMed Web of Science ®Google Scholar
• Sacco A, Battaglia AM, Botta C, et al. Iron metabolism in the tumor microenvironment-implications for anti-cancer immune response. Cells. 2021;10(2):303. doi:10.3390/cells10020303
   PubMed Web of Science ®Google Scholar
• Tang LQ, Li CF, Li J, et al. Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma. J Natl Cancer Inst. 2016;108(1):djv291. doi:10.1093/jnci/djv291
   PubMedGoogle Scholar